BOT

5.48%

34.5¢ botanix pharmaceuticals ltd

Be amused Be efarmer, a new study (...

First 184 Last

Share
Profile

Follow
aburbe

1,400 Posts.

560

19/04/19

09:17

Post #: 38209400
Share

Originally posted by beefarmer: ↑

Let's not all get ahead of our selves. Yes we know it is all huge but how huge? No one knows do they.

Now can I share with you a priapismic posting, a quote a few months ago however I do not know who is attributed to it due to the shody journalism in prose. It's a choice of two but the comparison is laughable and whilst any publicity is good publicity, this talk is pure baloney.

"I think it's going to be really significant. It's the only time in my career we've had a drug that cures a lot of diseases and it doesn't seem to cause side effects."

Botanix is holding clinical trials on a CBD gel to treat acne and dermatitis, and Mr Callahan says early results are promising.
Medlab Clinical meanwhile is investigating using a mix of CBD and THC - the compound that gives cannabis users their high - via a cheek spray to treat pain in cancer patients.
"We've got clinical trials going on at Sydney Royal North Shore Hospital that are progressing nicely; the data from them is sensational," says chief executive Sean Hall.
"We're looking down the face of a potentially another Lipitor."
That's a bold claim, given that the cholesterol-lowering drug made Pfizer as much as $A18 billion a year during the 2000s.

So we await and in the interim amuse ourselves with gentle banter throwing up all sorts of curve balls and distractions. What does impress me is the professionalism of our Board albeit they seem to be very quiet. Permetrex by itself may pay for a round of coffees but the big 3 results await.

Expand

Be amused Be efarmer, a new study ( https://pubs.acs.org/doi/10.1021/acs.molpharmaceut.8b01344 ) bodes well for the outcomes of that other transdermal CBD gel trial currently running ( https://zynerba.com/in-development/zygel/ ) and targeting autism. Could it pave the way to BTX1503 being prescribed to settle those kids down with a peachy complexion? Mens sana in corpore sano?

Last edited by aburbe: 19/04/19

BOT Price at posting: 10.5¢ Sentiment: Buy Disclosure: Held
6 Upvote

0 Great analysis

Reply

Top Stories

Week 26 Wrap: Cerberus of inflation barks – rents, electricity & fuel – and world watches two elders bicker

AVA

Ava Risk Group expands US presence with A$0.7M Substation Deal

SVL

Silver Mines models five new calderas close to 396Moz Bowdens deposit

CMX

ChemX Materials kicks off first stage works at WA high purity alumina pilot

RCE

Recce's R327 found effective against E.coli during clinical trial

SS1

Sun Silver gets that drill to thrill feeling from high grade hits at Maverick Spring

Wealth Within weighs in on shock 4% inflation read – and stocks that could survive the gloom

LRV

Larvotto identifies new exploration target at NSW's Hillgrove, boosting shares by nearly 20%

LU7

Lithium Universe (ASX:LU7) board visits Quebec to engage key stakeholders

Microcap Wrap: 5 explorers with news out today

There are more pages in this discussion • 1,540 more messages in this thread...

First 184 Last

Add BOT (ASX) to my watchlist

(20min delay)
Last 34.5¢		Change -0.020(5.48%)		Mkt cap ! $543.4M

Open	High	Low	Value	Volume
35.5¢	35.5¢	34.0¢	$4.566M	13.13M

Buyers (Bids)

No.	Vol.	Price($)
11	410003	34.5¢

Sellers (Offers)

Price($)	Vol.	No.
35.0¢	346713	8

View Market Depth

No.	Vol.	Price($)
9	403003	0.345
16	304864	0.340
12	887560	0.335
25	2286069	0.330
5	853843	0.325

Price($)	Vol.	No.
0.350	346713	8
0.355	48198	4
0.360	261992	7
0.365	522058	4
0.370	319527	7

Last trade - 16.10pm 28/06/2024 (20 minute delay)

BOT (ASX) Chart

Be amused Be efarmer, a new study (...

Week 26 Wrap: Cerberus of inflation barks – rents, electricity & fuel – and world watches two elders bicker

Ava Risk Group expands US presence with A$0.7M Substation Deal

Silver Mines models five new calderas close to 396Moz Bowdens deposit

ChemX Materials kicks off first stage works at WA high purity alumina pilot

Recce's R327 found effective against E.coli during clinical trial

Sun Silver gets that drill to thrill feeling from high grade hits at Maverick Spring

Wealth Within weighs in on shock 4% inflation read – and stocks that could survive the gloom

Larvotto identifies new exploration target at NSW's Hillgrove, boosting shares by nearly 20%

Lithium Universe (ASX:LU7) board visits Quebec to engage key stakeholders

Microcap Wrap: 5 explorers with news out today

Featured News

Buyers (Bids)

Sellers (Offers)

Featured News

Be amused Be efarmer, a new study (...

Top Stories

Week 26 Wrap: Cerberus of inflation barks – rents, electricity & fuel – and world watches two elders bicker

Ava Risk Group expands US presence with A$0.7M Substation Deal

Silver Mines models five new calderas close to 396Moz Bowdens deposit

ChemX Materials kicks off first stage works at WA high purity alumina pilot

Recce's R327 found effective against E.coli during clinical trial

Sun Silver gets that drill to thrill feeling from high grade hits at Maverick Spring

Wealth Within weighs in on shock 4% inflation read – and stocks that could survive the gloom

Larvotto identifies new exploration target at NSW's Hillgrove, boosting shares by nearly 20%

Lithium Universe (ASX:LU7) board visits Quebec to engage key stakeholders

Microcap Wrap: 5 explorers with news out today

Featured News

Buyers (Bids)

Sellers (Offers)

Featured News